febuxostat (Q22166): Difference between revisions
Jump to navigation
Jump to search
Created claim: chemical formula (P218): C₁₆H₁₆N₂O₃S |
Added link to [en]: Febuxostat |
||
| (5 intermediate revisions by the same user not shown) | |||
| Property / medical condition treated | |||
| Property / medical condition treated: hyperuricemia / rank | |||
Normal rank | |||
| Property / medical condition treated | |||
| Property / medical condition treated: gout / rank | |||
Normal rank | |||
| Property / subject has role | |||
| Property / subject has role: antigout agent / rank | |||
Normal rank | |||
| Property / subject has role | |||
| Property / subject has role: xanthine oxidase inhibitor / rank | |||
Normal rank | |||
| Property / Commons category | |||
Febuxostat | |||
| Property / Commons category: Febuxostat / rank | |||
Normal rank | |||
| links / en / name | links / en / name | ||
Latest revision as of 20:14, 22 April 2024
chemical compound
- Adenuric®
- MX-67
- Tei 6720
- Tei-6720
- TMX 67
- Uloric®
- Fébuxostat
- Febuxostatum
- Febuxostat
- 2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | febuxostat |
chemical compound |
|
Statements
C₁₆H₁₆N₂O₃S
0 references
Febuxostat
0 references